Fennec Pharmaceuticals Inc

Fennec Pharmaceuticals is a biotechnology company based in Research Triangle Park, North Carolina, dedicated to improving the lives of children undergoing chemotherapy. We focus on mitigating the debilitating side effects of cisplatin-based treatment, specifically, preventing cisplatin-induced ototoxicity – hearing loss. Our mission is to provide a critical solution for young cancer patients and their families, offering hope and preserving their auditory health. We achieve this through the development of innovative therapies, like Pedmark, and through rigorous research and clinical trials. Fennec Pharmaceuticals is committed to advancing pediatric oncology care and ensuring a brighter future for these vulnerable patients.

We serve children facing cancer treatment, their families, and the medical community involved in their care. Our work directly addresses a significant unmet need – the often-overlooked impact of chemotherapy on a child’s quality of life. We collaborate with leading researchers and healthcare professionals to translate scientific discoveries into tangible benefits for patients.

What distinguishes Fennec Pharmaceuticals is our unwavering focus on a single, critical challenge: protecting children’s hearing. We are a dedicated team of scientists and professionals driven by a profound commitment to patient well-being. Our ongoing research and development efforts are fueled by a desire to make a lasting difference in the lives of young cancer patients.